| Reportable Segment Information |
Reportable segment and corporate information for the interim periods is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2022 |
|
Net revenues - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third-party |
|
$ |
39,366 |
|
|
$ |
17,536 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
56,902 |
|
Inter-segment |
|
|
86 |
|
|
|
8 |
|
|
|
— |
|
|
|
(94 |
) |
|
|
— |
|
|
|
|
3,160 |
|
|
|
5,383 |
|
|
|
(36,693 |
) |
|
|
35 |
|
|
|
(28,115 |
) |
Goodwill (December 31, 2022) |
|
|
94,432 |
|
|
|
26,135 |
|
|
|
— |
|
|
|
— |
|
|
|
120,567 |
|
Other intangible assets, net (December 31, 2022) |
|
|
71,570 |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
71,572 |
|
Total assets (December 31, 2022) |
|
|
353,997 |
|
|
|
102,775 |
|
|
|
— |
|
|
|
(9 |
) |
|
|
456,763 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net revenues - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Third-party |
|
$ |
33,204 |
|
|
$ |
55,137 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
88,341 |
|
Inter-segment |
|
|
34 |
|
|
|
55 |
|
|
|
— |
|
|
|
(89 |
) |
|
|
— |
|
Operating income (loss) |
|
|
(1,763 |
) |
|
|
26,602 |
|
|
|
(4,571 |
) |
|
|
15 |
|
|
|
20,283 |
|
Goodwill (September 30, 2022) |
|
|
94,412 |
|
|
|
21,890 |
|
|
|
— |
|
|
|
— |
|
|
|
116,302 |
|
Other intangible assets, net (September 30, 2022) |
|
|
74,129 |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
74,131 |
|
Total assets (September 30, 2022) |
|
|
357,630 |
|
|
|
105,511 |
|
|
|
— |
|
|
|
(44 |
) |
|
|
463,097 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes acquisition and transaction related costs and litigation and select legal costs of $34,048 and $281 in the three months ended December 31, 2022 and 2021, respectively. |
(2) |
Eliminations consist of inter-segment transactions.
|
|
| Pre-tax Earnings Table |
A reconciliation of reportable segment operating income (loss) to consolidated earnings (loss) before income taxes is as follows:
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diagnostics segment |
|
$ |
3,160 |
|
|
$ |
(1,763) |
|
Life Science segment |
|
|
5,383 |
|
|
|
26,602 |
|
Eliminations |
|
|
35 |
|
|
|
15 |
|
| |
|
|
|
|
|
|
|
|
Total operating income |
|
|
8,578 |
|
|
|
24,854 |
|
Corporate expenses |
|
|
(36,693 |
) |
|
|
(4,571 |
) |
Interest income |
|
|
3 |
|
|
|
1 |
|
Interest expense |
|
|
(148 |
) |
|
|
(372 |
) |
Other, net |
|
|
(837 |
) |
|
|
(161 |
) |
| |
|
|
|
|
|
|
|
|
Consolidated earnings (loss) before income taxes |
|
$ |
(29,097 |
) |
|
$ |
19,751 |
|
| |
|
|
|
|
|
|
|
|
|
| Consolidated Net Revenues |
Three individual Diagnostics and two Life Science segment customers, including their affiliates, comprising 10% or more of reportable segment net revenues were as follows:
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer A |
|
|
7 |
% |
|
|
10 |
% |
Customer B |
|
|
10 |
% |
|
|
11 |
% |
Customer C |
|
|
12 |
% |
|
|
11 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
— |
% |
|
|
23 |
% |
|
|
|
4 |
% |
|
|
14 |
% |
|
|
|
12 |
% |
|
|
5 |
% | In addition, one of the Life Science segment customers, including their affiliates, identified above accounted for greater than 10% of consolidated net revenues as follows:
|
|
|
|
|
|
|
|
|
Three Months Ended December 31, |
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer D |
|
|
— |
% |
|
|
14 |
% |
|